Quantitative Measurement of the Affinity of Toxic and Nontoxic Misfolded Protein Oligomers for Lipid Bilayers and of its Modulation by Lipid Composition and Trodusquemine

Silvia Errico, Hassan Ramshini, Claudia Capitini, Claudio Canale, Martina Spaziano, Denise Barbut, Martino Calamai, Michael Zasloff, Reinier Oropesa‐Nuñez, Michele Vendruscolo, Fabrizio ChitiACS 2021 · DOI

TL;DR

This study quantitatively measures the binding affinity of toxic versus non-toxic protein oligomers to lipid membranes, revealing that toxic oligomers bind 20-25 times more strongly. The research also demonstrates that a drug candidate, trodusquemine, can effectively block this binding, and that lipid composition significantly influences oligomer-membrane interactions, offering new insights into neurodegenerative disease mechanisms and potential therapeutic strategies.

What Problem Does This Paper Address?

Neurodegenerative diseases like Alzheimer's and Parkinson's are often linked to the aggregation of proteins into misfolded structures. While the final amyloid fibrils are well-studied, soluble oligomers formed during this process are increasingly recognized as key culprits in cellular toxicity. These oligomers are thought to exert their damaging effects by interacting with neuronal cell membranes. However, a critical gap in understanding has been the quantitative measurement of how strongly these different oligomeric species bind to membranes and what factors influence this binding. Without this quantitative data, it's difficult to fully grasp the mechanisms of toxicity and to design effective drugs that can interfere with these interactions. This paper aims to fill this gap by precisely measuring the binding affinities of toxic and non-toxic oligomers to artificial lipid bilayers and exploring how lipid composition and a potential therapeutic agent affect these interactions.

Methods

The researchers employed a multi-pronged approach to quantitatively assess oligomer-membrane interactions:

  • Fluorescence Quenching: They used liposomes (artificial cell membranes) embedded with fluorescent probes (TMA-DPH and DPH) in both the polar head and apolar regions. When toxic or non-toxic oligomers bind to the membrane, they can quench the fluorescence of these probes. By measuring the degree of quenching, they could determine the Stern-Volmer constant ($K_{sv}$), which reflects the oligomer's affinity for the membrane-bound probes and, by extension, the membrane itself.
  • Protein-Oligomer Binding Assay: They labeled the protein oligomers with a fluorescent dye (BODIPY FL) and then incubated them with unlabeled liposomes. By measuring the change in fluorescence intensity of the labeled oligomers as a function of liposome concentration, they could determine the dissociation constant ($K_D$), providing a direct measure of binding affinity.
  • Structural Analysis (CD, Intrinsic Fluorescence, FRET): To ensure that the observed binding wasn't due to structural changes in the oligomers upon membrane interaction, they used Circular Dichroism (CD) to assess secondary structure, intrinsic tryptophan fluorescence to probe the local environment, and Förster Resonance Energy Transfer (FRET) to monitor intramolecular distances.
  • Lipid Composition Modulation: They systematically varied the concentrations of key lipids, specifically GM1 ganglioside and cholesterol, in the liposomes to see how these changes affected the binding affinity of the toxic oligomers.
  • Drug Intervention: They investigated the effect of trodusquemine, a known membrane-penetrating molecule, on oligomer binding by including it in the liposomes and repeating the fluorescence quenching and binding assays.

Datasets

Not discussed in the paper. The study utilizes synthetic liposomes as model membranes and protein oligomers derived from the HypF-N protein domain.

Key Insights and Ideas

  • Toxicity Correlates with Binding Strength: The most striking finding is the direct quantitative link between an oligomer's toxicity and its affinity for lipid membranes. Toxic oligomers are significantly more "sticky" to membranes than their non-toxic counterparts.
  • Structural Stability is Key: The fact that neither toxic nor non-toxic oligomers change their fundamental structure upon membrane binding suggests that their inherent structural differences, rather than induced conformational changes, dictate their membrane interaction and subsequent toxicity.
  • Membrane Composition is a Critical Regulator: The study highlights that cell membranes are not passive targets. Their lipid composition actively influences how strongly toxic oligomers can bind, offering a potential avenue for therapeutic intervention by modifying membrane properties.
  • Trodusquemine as a Potent Blocker: The demonstration that trodusquemine can almost completely prevent toxic oligomer binding at protective concentrations is a significant finding, validating its potential as a therapeutic agent by directly interfering with a key step in the toxicity pathway.

Key Results

  • Affinity Difference: Toxic oligomers (OAs) exhibited a membrane affinity 20-25 times higher than non-toxic oligomers (OBs), as measured by both Stern-Volmer ($K_{sv}$) and dissociation ($K_D$) constants.
  • Native Protein Insignificance: Native, non-misfolded HypF-N protein showed negligible binding to the liposomes.
  • Structural Integrity: CD, intrinsic fluorescence, and FRET analyses confirmed that both OA and OB oligomers maintained their secondary and tertiary structures upon interaction with liposomes.
  • Trodusquemine Efficacy: Trodusquemine significantly reduced the binding affinity of OAs to liposomes, decreasing the $K_D$ by approximately one order of magnitude. At protective concentrations, it almost completely prevented OA-LUV binding.
  • Lipid Composition Effects:
    • Increasing GM1 ganglioside content in liposomes led to a significant increase in OA binding affinity.
  • Increasing cholesterol content resulted in a slight decrease in OA binding affinity.

Limitations and Future Work

  • Model System: While liposomes provide a controlled environment, they are simplifications of complex biological membranes. Future work could explore these interactions in more physiologically relevant membrane systems or cellular models.
  • Specific Oligomer Type: The study focused on oligomers derived from the HypF-N protein. While this protein serves as a valuable model, extending these quantitative analyses to oligomers from disease-associated proteins (e.g., Aβ, α-synuclein) would be crucial.
  • Mechanism of Trodusquemine: While trodusquemine's protective effect is shown, further investigation into its precise molecular mechanism of interaction with both the membrane and the oligomers could be beneficial.
  • Therapeutic Translation: The findings on trodusquemine and lipid modulation offer promising avenues for drug development and strategies to enhance neuronal resilience against protein oligomer toxicity. Future work could focus on translating these insights into therapeutic interventions.

Summary updated

Abstract

Many neurodegenerative diseases are associated with the self-assembly of peptides and proteins into fibrillar aggregates. Soluble misfolded oligomers formed during the aggregation process, or released by mature fibrils, play a relevant role in neurodegenerative processes through their interactions with neuronal membranes. However, the determinants of the cytotoxicity of these oligomers are still unclear. Here we used liposomes and toxic and nontoxic oligomers formed by the same protein to measure quantitatively the affinity of the two oligomeric species for lipid membranes. To this aim, we quantified the perturbation to the lipid membranes caused by the two oligomers by using the fluorescence quenching of two probes embedded in the polar and apolar regions of the lipid membranes and a well-defined protein-oligomer binding assay using fluorescently labeled oligomers to determine the Stern-Volmer and dissociation constants, respectively. With both approaches, we found that the toxic oligomers have a membrane affinity 20-25 times higher than that of nontoxic oligomers. Circular dichroism, intrinsic fluorescence, and FRET indicated that neither oligomer type changes its structure upon membrane interaction. Using liposomes enriched with trodusquemine, a potential small molecule drug known to penetrate lipid membranes and make them refractory to toxic oligomers, we found that the membrane affinity of the oligomers was remarkably lower. At protective concentrations of the small molecule, the binding of the oligomers to the lipid membranes was fully prevented. Furthermore, the affinity of the toxic oligomers for the lipid membranes was found to increase and slightly decrease with GM1 ganglioside and cholesterol content, respectively, indicating that physicochemical properties of lipid membranes modulate their affinity for misfolded oligomeric species.
BibTeX
@inproceedings{errico2021quantitative,
  author = {Silvia Errico and Hassan Ramshini and Claudia Capitini and Claudio Canale and Martina Spaziano and Denise Barbut and Martino Calamai and Michael Zasloff and Reinier Oropesa‐Nuñez and Michele Vendruscolo and Fabrizio Chiti},
  title = {{Quantitative Measurement of the Affinity of Toxic and Nontoxic Misfolded Protein Oligomers for Lipid Bilayers and of its Modulation by Lipid Composition and Trodusquemine}},
  booktitle = {ACS},
  year = {2021},
  doi = {10.1021/acschemneuro.1c00327},
}
Figure